Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NRC HEALTHNRC · Entity 5534 | EVP, Strategic Insights | January 05, 2026 | January 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NRC HEALTH
Report date January 05, 2026 · Filed January 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,000 |
Reported balance
After 2026-01-05 transaction · row 1
1 source rowRow 1 · 2026-01-05 · Grant · Acquired 100,000 · Balance 100,000 F1: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares will vest in three approximately equal installments on the following dates: (i) January 5, 2027, (ii) January 5, 2028, and (iii) January 5, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares will vest in three approximately equal installments on the following dates: (i) January 5, 2027, (ii) January 5, 2028, and (iii) January 5, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2026 Filed Jan 16, 2026 21:13 UTC | NRC HEALTH NRC · Entity 5534 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001008886-26-000012 · form4.xml · nonDerivative · entry 1 Burik David · CIK 0002105843 · EVP, Strategic Insights 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · kind: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares will vest in three approximately equal installments on the following dates: (i) January 5, 2027, (ii) January 5, 2028, and (iii) January 5, 2029. F1 · shares: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares will vest in three approximately equal installments on the following dates: (i) January 5, 2027, (ii) January 5, 2028, and (iii) January 5, 2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.